Retatrutide UPRET 30 - Vial

The UPA UPRET Retatrutide Vial 30mg is a premium triple-agonist peptide therapy designed for advanced weight management, appetite control, and metabolic optimization. Developed and formulated by UPA, this vial contains 30mg of Retatrutide in a convenient format suitable for structured wellness and weight-loss programs. Retatrutide targets GLP-1, GIP, and glucagon receptors, helping reduce cravings, enhance satiety, and support overall metabolic efficiency.

Properties and Mechanism of Action

UPA UPRET Retatrutide is a triple-agonist peptide that works through three complementary metabolic pathways:

• GLP-1 receptor activation – promotes appetite suppression and improved satiety
• GIP receptor activation – supports insulin sensitivity and efficient energy utilization
• Glucagon receptor activation – aids fat metabolism and overall metabolic balance

This triple-receptor mechanism provides comprehensive metabolic support and optimized weight-management outcomes.